Package 55154-8713-8

{"route": ["ORAL"], "spl_id": "b37c24b7-9678-407d-a6be-560252ed6dc3", "openfda": {"nui": ["N0000185008", "N0000185007", "N0000182137", "N0000190114", "N0000185503"], "upc": ["0355154871380", "0355154871281"], "unii": ["MVR3JL3B2V"], "rxcui": ["1300791", "1300797", "1300801", "1300803"], "spl_set_id": ["aaaf3bea-1b21-4edf-9300-b7159ea9ede8"], "pharm_class_epc": ["beta3-Adrenergic Agonist [EPC]"], "pharm_class_moa": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1080 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (55154-8713-8)", "package_ndc": "55154-8713-8", "marketing_end_date": "20260430", "marketing_start_date": "20120628"}], "brand_name": "Myrbetriq", "product_id": "55154-8713_b37c24b7-9678-407d-a6be-560252ed6dc3", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "beta3-Adrenergic Agonist [EPC]"], "product_ndc": "55154-8713", "generic_name": "mirabegron", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Myrbetriq", "active_ingredients": [{"name": "MIRABEGRON", "strength": "50 mg/1"}], "application_number": "NDA202611", "marketing_category": "NDA", "marketing_end_date": "20260430", "marketing_start_date": "20120628"}